Table of Contents
Chemotherapy Research and Practice
Volume 2016 (2016), Article ID 7295390, 6 pages
http://dx.doi.org/10.1155/2016/7295390
Research Article

Interferon-Gamma Improves Macrophages Function against M. tuberculosis in Multidrug-Resistant Tuberculosis Patients

1Department of Microbiology, Kohat University of Science and Technology, KPK, Kohat 26000, Pakistan
2Department of Biotechnology, Kohat University of Science and Technology, KPK, Kohat 26000, Pakistan
3Department of Immunology, Armed Forces Institute of Pathology, Rawalpindi 46000, Pakistan

Received 6 March 2016; Accepted 14 June 2016

Academic Editor: Enzo Bonmassar

Copyright © 2016 Taj Ali Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Rastogi, E. Legrand, and C. Sola, “The mycobacteria: an introduction to nomenclature and pathogenesis,” Revue Scientifique et Technique, vol. 20, no. 1, pp. 21–54, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. A. K. Azad, W. Sadee, and L. S. Schlesinger, “Innate immune gene polymorphisms in tuberculosis,” Infection and Immunity, vol. 80, no. 10, pp. 3343–3359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Liu, J. Yan, Q. Wan, Q. Ye, and Y. Huang, “The risk factors for tuberculosis in liver or kidney transplant recipients,” BMC Infectious Diseases, vol. 14, article 387, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Deffert, J. Cachat, and K.-H. Krause, “Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections,” Cellular Microbiology, vol. 16, no. 8, pp. 1168–1178, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione, “Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project,” The Journal of the American Medical Association, vol. 282, no. 7, pp. 677–686, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Zhang, D. Li, L. Zhao et al., “Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance,” Nature Genetics, vol. 45, no. 10, pp. 1255–1260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. O'Garra, P. S. Redford, F. W. McNab, C. I. Bloom, R. J. Wilkinson, and M. P. R. Berry, “The immune response in tuberculosis,” Annual Review of Immunology, vol. 31, pp. 475–527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. P. R. Errante, J. B. Frazão, and A. Condino-Neto, “The use of interferon-gamma therapy in chronic granulomatous disease,” Recent Patents on Anti-Infective Drug Discovery, vol. 3, no. 3, pp. 225–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Nunes-Alves, M. G. Booty, S. M. Carpenter, P. Jayaraman, A. C. Rothchild, and S. M. Behar, “In search of a new paradigm for protective immunity to TB,” Nature Reviews Microbiology, vol. 12, no. 4, pp. 289–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Romani, “Immunity to fungal infections,” Nature Reviews Immunology, vol. 11, no. 4, pp. 275–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Wang, Y. Cai, Q. Cheng, Y. Hu, and H. Xiao, “Imbalance of Th1/Th2 cytokines in patients with pulmonary tuberculosis,” Zhonghua Jie He He Hu Xi Za Zhi, vol. 25, no. 9, pp. 535–537, 2002. View at Google Scholar · View at Scopus
  12. K. I. Masood, M. E. Rottenberg, B. Carow et al., “SOCS1 gene expression is increased in severe pulmonary tuberculosis,” Scandinavian Journal of Immunology, vol. 76, no. 4, pp. 398–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Y. Patel, R. Doffinger, G. Barcenas-Morales, and D. S. Kumararatne, “Genetically determined susceptibility to mycobacterial infection,” Journal of Clinical Pathology, vol. 61, no. 9, pp. 1006–1012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Esquivel-Solís, F. Quiñones-Falconi, A. Zarain-Herzberg, R. I. Amieva-Fernández, and Y. López-Vidal, “Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis,” Clinical and Experimental Immunology, vol. 158, no. 1, pp. 45–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Feinberg, C. Fieschi, R. Doffinger et al., “Bacillus Calmette Guérin triggers the IL-12/IFN-γ axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes,” European Journal of Immunology, vol. 34, no. 11, pp. 3276–3284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. V. L. Petricevich, C. Ueda, R. C. B. Alves et al., “A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice,” Brazilian Journal of Medical and Biological Research, vol. 34, no. 1, pp. 81–92, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Hasui, Y. Hirabayashi, and Y. Kobayashi, “Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood,” Journal of Immunological Methods, vol. 117, no. 1, pp. 53–58, 1989. View at Publisher · View at Google Scholar · View at Scopus
  18. T. A. Khan, O. Cabral-Marques, L. F. Schimke et al., “Tuberculosis in an autosomal recessive case of chronic granulomatous disease due to mutation of the NCF1 gene,” Allergologia et Immunopathologia, vol. 44, no. 3, pp. 276–279, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. X.-F. Gao, Z.-W. Yang, and J. Li, “Adjunctive therapy with interferon-γ for the treatment of pulmonary tuberculosis: a systematic review,” International Journal of Infectious Diseases, vol. 15, no. 9, pp. e594–e600, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. V. N. Cavalcanti, M. C. A. Brelaz, J. K. D. A. L. Neves, J. C. Ferraz, and V. R. A. Pereira, “Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis,” Pulmonary Medicine, vol. 2012, Article ID 745483, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. F. Djoba Siawaya, N. Beyers, P. van Helden, and G. Walzl, “Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis,” Clinical and Experimental Immunology, vol. 156, no. 1, pp. 69–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. P. P. Singh and A. Goyal, “Interleukin-6: a potent biomarker of mycobacterial infection,” SpringerPlus, vol. 2, article 686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Carranza, E. Juárez, M. Torres, J. J. Ellner, E. Sada, and S. K. Schwander, “Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 2, pp. 238–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Alcaïs, L. Abel, and J.-L. Casanova, “Human genetics of infectious diseases: between proof of principle and paradigm,” The Journal of Clinical Investigation, vol. 119, no. 9, pp. 2506–2514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Alcaïs, L. Quintana-Murci, D. S. Thaler, E. Schurr, L. Abel, and J.-L. Casanova, “Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity?” Annals of the New York Academy of Sciences, vol. 1214, no. 1, pp. 18–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-L. Casanova and L. Abel, “Primary immunodeficiencies: a field in its infancy,” Science, vol. 317, no. 5838, pp. 617–619, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Bogunovic, S. Boisson-Dupuis, and J.-L. Casanova, “ISG15: leading a double life as a secreted molecule,” Experimental & Molecular Medicine, vol. 45, p. e18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-L. Casanova and L. Abel, “Genetic dissection of immunity to mycobacteria: the human model,” Annual Review of Immunology, vol. 20, pp. 581–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. R. van Crevel, T. H. M. Ottenhoff, and J. W. M. van der Meer, “Innate immunity to Mycobacterium tuberculosis,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 294–309, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. R. A. B. Ezekowitz, C. A. Sieff, M. C. Dinauer, D. G. Nathan, S. H. Orkin, and P. E. Newburger, “Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell,” Blood, vol. 76, no. 12, pp. 2443–2448, 1990. View at Google Scholar · View at Scopus
  31. R. C. Woodman, R. W. Erickson, J. Rae, H. S. Jaffe, and J. T. Curnutte, “Prolonged recombinant interferon-γ therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity,” Blood, vol. 79, no. 6, pp. 1558–1562, 1992. View at Google Scholar · View at Scopus